Resource Center
Resource Center
After five hours hunched in a crowded minibus, three hours trying to soothe a crying baby, and one hour waiting to see a healthcare worker, she had made it. This Malawian mother had finally made it to a health facility to test her baby for HIV. Despite the hours of travel, she soon learned that...
Read more
Seventeen years: This is how long it typically takes for a scientifically tested intervention to be integrated into standard practice, according to experts. But can this gap between research and policy be closed? Health sector stakeholders in Rwanda are trying to do just that. On Friday August 24th, the Rwandan Ministry of Health, the Rwanda...
Read more
In 2015, HIV was the cause of 19 percent of all childhood deaths under the age of five in Lesotho. Previous strategies to identify and treat children who were living with HIV had proven ineffective and Lesotho’s goal to reach 80 percent of children living with HIV had fallen short, with only 30 percent of...
Read more
As we welcome another World Hepatitis Day, the global response to eliminate viral hepatitis as a public threat is accelerating. Viral hepatitis, consisting of hepatitis B (HBV) and hepatitis C (HCV), affects more than 320 million people worldwide, with 90 percent of infections concentrated in low- and middle-income countries. The disease leads to significant liver...
Read more
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...
Read more
We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and is a key feature of Unitaid’s US$34 million Optimal Antiretroviral (ARV) grant to CHAI. The optimal...
Read more
In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked with the Vietnamese government to pilot a national public sector HCV care and...
Read more
Introducing the second edition of CHAI’s HIV Mid-Year Market Memo, an informational brief that covers the latest trends in the HIV space in low- and middle-income countries (LMICs) since the publication of CHAI’s annual ARV Market Report in September 2017. See the HIV Mid-Year Market Memo here. See the 2017 ARV Market Report here.
Read more
Tuberculosis (TB) claims more lives each year than any other infectious disease – a global total of 1.4 million deaths. India accounts for one-third of these, along with 2.7 million new cases each year. The disease afflicts both rural and urban areas, but crowded mega-cities are major sources of new infection.
Read more
View the Clinton Health Access Initiative, Inc. and Subsidiaries’ 2017 Consolidated Financial Statements.
Read more